289 related articles for article (PubMed ID: 31244350)
21. Comparison of outcomes between hemithyroidectomy alone and hemithyroidectomy with elective unilateral central neck dissection in patients with papillary thyroid microcarcinoma.
Son HJ; Kim JK; Jung YD; Jang GH; Seo YT; Kim DS; Park SH; Jeong YJ
Head Neck; 2018 Nov; 40(11):2449-2454. PubMed ID: 30302890
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound-Guided Laser Ablation Versus Microwave Ablation for Patients With Unifocal Papillary Thyroid Microcarcinoma: A Retrospective Study.
Zhou W; Ni X; Xu S; Zhang L; Chen Y; Zhan W
Lasers Surg Med; 2020 Nov; 52(9):855-862. PubMed ID: 32216112
[TBL] [Abstract][Full Text] [Related]
23. A feasibility study of microwave ablation for papillary thyroid cancer close to the thyroid capsule.
Wu J; Zhao ZL; Cao XJ; Wei Y; Peng LL; Li Y; Yu MA
Int J Hyperthermia; 2021; 38(1):1217-1224. PubMed ID: 34384314
[TBL] [Abstract][Full Text] [Related]
24. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Follow-Up Results of Ultrasound-Guided Radiofrequency Ablation for Low-Risk Papillary Thyroid Microcarcinoma: More Than 5-Year Follow-Up for 84 Tumors.
Cho SJ; Baek SM; Lim HK; Lee KD; Son JM; Baek JH
Thyroid; 2020 Dec; 30(12):1745-1751. PubMed ID: 32375570
[No Abstract] [Full Text] [Related]
26. A preliminary study of microwave ablation for solitary T1N0M0 papillary thyroid carcinoma with capsular invasion.
Wu J; Wei Y; Zhao ZL; Peng LL; Li Y; Lu NC; Yu MA
Int J Hyperthermia; 2022; 39(1):372-378. PubMed ID: 35184656
[TBL] [Abstract][Full Text] [Related]
27. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study.
Teng DK; Li HQ; Sui GQ; Lin YQ; Luo Q; Fu P; Du JR; Jin CX; Wang H
Endocrine; 2019 Apr; 64(1):109-117. PubMed ID: 30771153
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study.
Han ZY; Dou JP; Zheng L; Che Y; Yu MA; Wang SR; Wang H; Cong ZB; He JF; Qian TG; Hu QH; He GZ; Liu G; Yu SY; Guo JQ; Jiang TA; Feng RF; Li QY; Chen XJ; Zhu YL; Wei Y; Liu LH; Wang X; Qi LN; Liang P
Eur Radiol; 2023 Nov; 33(11):7942-7951. PubMed ID: 37294329
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation for Treating Low-Risk Papillary Thyroid Microcarcinoma: A Prospective Study.
Zhang M; Luo Y; Zhang Y; Tang J
Thyroid; 2016 Nov; 26(11):1581-1587. PubMed ID: 27445090
[TBL] [Abstract][Full Text] [Related]
31. Pathology confirmation of the efficacy and safety of microwave ablation in papillary thyroid carcinoma.
Ding M; Wu GS; Gu JH; Shen DJ; Zhou R; Liu Y; Xie RL; Wang SR; Wang HC; Fei J
Front Endocrinol (Lausanne); 2022; 13():929651. PubMed ID: 35983517
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy and safety of ultrasound-guided radiofrequency ablation and microwave ablation for the treatment of unifocal papillary thyroid microcarcinoma: a retrospective study.
Li N; Dong Y; Ding Y; Cui G; Hua Q; Xia S; Zhou J
Int J Hyperthermia; 2024; 41(1):2287964. PubMed ID: 38223997
[TBL] [Abstract][Full Text] [Related]
33. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
34. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Prognosis of Unilateral and Multifocal Papillary Thyroid Microcarcinoma After Unilateral Lobectomy Versus Total Thyroidectomy.
Jeon YW; Gwak HG; Lim ST; Schneider J; Suh YJ
Ann Surg Oncol; 2019 Sep; 26(9):2952-2958. PubMed ID: 31264119
[TBL] [Abstract][Full Text] [Related]
36. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
37. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma.
Caliskan M; Park JH; Jeong JS; Lee CR; Park SK; Kang SW; Jeong JJ; Chung WY; Park CS
Endocr J; 2012; 59(4):305-11. PubMed ID: 22240889
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of ultrasound-guided radiofrequency, microwave and laser ablation for the treatment of T1N0M0 papillary thyroid carcinoma on a large scale: a systematic review and meta-analysis.
Gao X; Yang Y; Wang Y; Huang Y
Int J Hyperthermia; 2023 Dec; 40(1):2244713. PubMed ID: 37604507
[TBL] [Abstract][Full Text] [Related]
39. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
40. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
